Business
bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications
Company enlists Havas Health & You, Trinity Life Sciences to help build CyPath® Lung brand SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc.
About this update from Bioaffinity Technologies, Inc.
[{"type":"text","content":"\nCompany enlists Havas Health & You, Trinity Life Sciences to help build CyPath® Lung brand\n\n SAN ANTONIO--(BUSINESS WIRE)--\nbioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW) today announced its commercialization team, including the addition of Julie Anne Overton, a veteran of print and broadcast journalism, corporate communications and federal public affairs, as bioAffinity Technologies’ Director of Communications, and the marketing and advertising firms of Havas Health & You and Trinity Life Sciences to help build the CyPath® Lung brand and position it for success in the cancer diagnostics sector.\n\nCyPath® Lung is a non-invasive test that detects early-stage lung cancer by automated flow cytometry and machine learning. “CyPath® Lung has the potential to change the paradigm for the detection of early-stage lung cancer, and we have selected a team that can build our brand with intention and establish a genuine connection with physicians and patients who put their trust in us,” bioAffinity Technologies President and CEO Maria Zannes said. “To that end, in addition to hiring Julie Anne, we have engaged firms with excellent credentials in the healthcare and biotech industries who will bring creativity, purpose and strategic thinking to our story.”\n\nHavas Health & You, the world’s largest global health network, is focused on promoting healthy living decisions across the entire health ecosystem. The firm is creating the branding and broader marketing strategy to align with the need for a patient-friendly diagnostic that gives physicians another tool to assess the potential or presence of lung cancer in their high-risk patients.\n\n“Working with partners that create innovative solutions for physicians and the patients they serve aligns directly with our network’s focus on human purpose,” said Jeff Hoffman, Chief Development Officer and Partner at Havas Health & You. “We’re so excited to work with bioAffinity during this next step of their journey as a company, and I can’t think of a more meaningful way to start our partnership with Trinity Life Sciences than through our work on this project together.”\n\nTrinity Life Sciences, a trusted strategic commercialization partner providing evidence-based solutions for the life sciences, is providing advisory services, insights and analytics to bioAffinity Technologies’ marketing st...